3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Genitourinary
1
Conditions
Fallopian Tube Neoplasms
5
Ovarian Neoplasms
4
Carcinoma, Ovarian Epithelial
3
Neoplasms
2
Recurrence
1
Prostatic Neoplasms
1
Pathologic Complete Response
1
Metastatic Castration Resistant Prostate Cancer
1
Genital Neoplasms, Male
1
Adenocarcinoma, Clear Cell
1
Interventions
padeliporfin
3
rucaparib
1
palladium-bacteriopheophorbide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Genital Neoplasms, Male
×
rucaparib
×
Clear all
NCT04676334
2024-05-07
CATCH-R
pharmaand GmbH
Phase 3
Completed
34 enrolled
9 charts